Tofacitinib, an oral JAK inhibitor, in the treatment of RA: safety and clinical and radiographic efficacy in open-label, long-term extension studies over 7 years
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY(2016)
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined